These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 579009)

  • 1. [Homologous and heterologous antibody induction in influenzal infection and immunization].
    Rudenko LG; Rafaél'skaia TI; Nesterenko LS
    Vopr Virusol; 1977; (4):477-80. PubMed ID: 579009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens.
    Smith AF; Davies JR
    J Hyg (Lond); 1977 Jun; 78(3):363-75. PubMed ID: 266540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 7. An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness.
    Greenberg SB; Couch RB; Kasel JA
    Am J Epidemiol; 1974 Sep; 100(3):209-15. PubMed ID: 4479059
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
    Ogra PL; Chow T; Beutner KR; Rubi E; Strussenberg J; DeMello S; Rizzone C
    J Infect Dis; 1977 Apr; 135(4):499-506. PubMed ID: 856917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influenza virus neuraminidase and its role in anti-influenzal immunity].
    Isaeva EI; Platonova AL; Rovnova ZI; Kosiakov PN
    Vopr Virusol; 1979; (6):615-9. PubMed ID: 524858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
    Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR
    Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genomic and antigenic analysis of strains of influenza A virus (H1N1) isolated in 1982-1983: approaches to the choice of the optimal vaccine strain].
    Akopova II; Klimov AI; Unanov SS; Krasnova VP; Grinbaum EB
    Vopr Virusol; 1986; 31(3):288-92. PubMed ID: 2429448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of parenteral and oral immunization against influenza in a large clinical trial. 2. Results of immunologic studies].
    Tischner H; Popp M; Hien NT; Finke EJ; Nordheim W; Bräuniger S; Werchan D; Luther P; Dittmann S
    Z Erkr Atmungsorgane; 1990; 175(3):147-54. PubMed ID: 1706903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.